Answers are grounded in this paper and cite their sources.
In England, national policy emphasises the need to integrate genomic testing into routine cancer care, positioning genomics as a core component of personalised treatment for patients. However, implementation remains variable. Since June 2024, the East of England Cancer Alliance has a team of genomic clinical practitioners whose task is to facilitate the implementation of genomic testing locally by supporting staff in cancer services to develop the competence to initiate testing. The authors conducted a service evaluation to explore the experiences of the team, asking them about barriers, facilitators, strategies and risks. Barriers to embedding genomic testing in routine cancer care included limited workforce knowledge, competing priorities, variable organisational support and inconsistent systems. Facilitators of genomic testing integration included targeted staff education, improved leadership, clearer guidance and enhanced collaboration. Overall, the authors concluded that a coordinated, multi-level approach addressing workforce capability, organisational support and system infrastructure is required to fully embed genomic testing in routine cancer care.
No takes yet. Share an insight, caveat, or question.
Lawrence et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: